123I-ioflupane brain SPECT and 123I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders. - Wikidata - awgldk - TriplyDB

123I-ioflupane brain SPECT and 123I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders.

123I-ioflupane brain SPECT and 123I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders.

http://www.wikidata.org/entity/Q33760571

about

Optimizing Parkinson's disease diagnosis: the role of a dual nuclear imaging algorithm.The Utility of the Combined Use of 123I-FP-CIT and 123I-MIBG Myocardial Scintigraphy in Differentiating Parkinson’s Disease from Other Parkinsonian Syndromes.

P2860

Q55339954-39D852E7-4B26-42D7-A4A0-4B2758B05783 Q55344774-84670C15-EB4D-458C-B054-2832BB447593

P2860

123I-ioflupane brain SPECT and 123I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders.

http://www.wikidata.org/entity/Q33760571

description

2017 nî lūn-bûn

@nan

2017 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

123I-ioflupane brain SPECT and ...... ertain parkinsonian disorders.

@ast

123I-ioflupane brain SPECT and ...... ertain parkinsonian disorders.

@en

type

label

123I-ioflupane brain SPECT and ...... ertain parkinsonian disorders.

@ast

123I-ioflupane brain SPECT and ...... ertain parkinsonian disorders.

@en

prefLabel

123I-ioflupane brain SPECT and ...... ertain parkinsonian disorders.

@ast

123I-ioflupane brain SPECT and ...... ertain parkinsonian disorders.

@en

P1433

Q33760571-AB61C129-0E42-4666-9678-54F7A013354A

P1476

Q33760571-0D685AD6-459B-4BA0-A081-ABAB72CE7111

P2093

Q33760571-2D1F666C-30C4-4F41-B613-255DE60CC247

Q33760571-541CE9FC-BBE5-4D25-8889-194C3EB00985

Q33760571-5D3FF352-870D-4C51-8DEB-A6C69CA07E2D

Q33760571-BA47F35C-645D-45A2-AE9D-9CD685C7C500

Q33760571-CC318588-8E8B-4605-B341-41B01A42584E

Q33760571-DCC2EC6A-FBEE-4D10-8C1E-ADCD953BEC73

P2860

Q33760571-03B0E9F2-D99D-47F2-A5A1-127854BC9C91

Q33760571-05C05E5F-584B-4A1D-B68C-9A3138C49387

Q33760571-0943C8F2-4731-4F86-B07D-BCA52398A742

Q33760571-10805A98-B9D9-4FA3-910D-573345E89275

Q33760571-12382812-5832-46EE-8423-D8FFDB111D51

Q33760571-1CDACE98-222C-4D02-BA01-ECE7F148AF03

Q33760571-1FDD1321-FBC9-4714-AB3A-2E49B925BD0A

Q33760571-2226799F-CA06-4056-9FFF-2A8C56A020A7

Q33760571-2228B27A-6564-4155-8361-CE4573225629

Q33760571-2647FB17-798E-4E7C-A61C-1E9E8B69A540

P304

Q33760571-2C510116-0D2C-4A99-A2D1-C7D27427EDFF

P31

Q33760571-4353E0FB-00E3-4D4D-9CFC-8F43EB9B60DB

P356

Q33760571-3E291740-1170-476D-AC1E-01D6FB0AC54B

P407

Q33760571-16DC374B-2B48-4399-B6B3-3C192E0232B3

P433

Q33760571-471BFDD4-30BC-4ABB-BE62-7A51DDA2B5F8

P478

Q33760571-4D46A269-D9FC-40AA-9FF6-61CBC37677CE

P50

Q33760571-2FAADB3C-6F92-47BE-9A53-F1458B07D3EE

Q33760571-473E2B1D-A85F-4B59-8F7E-C607D15641C7

Q33760571-501F1D46-34FF-464A-B123-AD08E0C213FB

P577

Q33760571-2620D854-5C15-45A9-8B58-3C2969940F66

P698

Q33760571-E1F6BB13-F22B-4D54-B34A-3AB0C379B04B

P921

Q33760571-3D5ACEFB-D58C-4247-A693-202DED318BAC

P932

Q33760571-04BFEDCF-3302-439D-B5F3-91AB607C0C64

P356

MD.0000000000006967

P1433

P1476

123I-ioflupane brain SPECT and ...... ertain parkinsonian disorders.

@en

P2093

Aldo Mulas

http://www.w3.org/2001/XMLSchema#string

Angela Spanu

http://www.w3.org/2001/XMLSchema#string

Antonio Nieddu

http://www.w3.org/2001/XMLSchema#string

Giuseppe Madeddu

http://www.w3.org/2001/XMLSchema#string

Maria Rita Piras

http://www.w3.org/2001/XMLSchema#string

Susanna Nuvoli

http://www.w3.org/2001/XMLSchema#string

P2860

The utility of neuroimaging in the differential diagnosis of parkinsonian syndromes

The diagnostic accuracy of dopamine transporter SPECT imaging to detect nigrostriatal cell loss in patients with Parkinson's disease or clinically uncertain parkinsonism: a systematic review.

Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis.

A comparative analysis of structural brain MRI in the diagnosis of Alzheimer's disease.

Clinical Implications of Cardiac-MIBG SPECT in the Differentiation of Parkinsonian Syndromes.

Vascular parkinsonism: what makes it different?

Vascular parkinsonism--an important cause of parkinsonism in older people.

When DLB, PD, and PSP masquerade as MSA: an autopsy study of 134 patients

Diagnostic accuracy of apparent diffusion coefficient and 123I-metaiodobenzylguanidine for differentiation of multiple system atrophy and Parkinson's disease.

EANM procedure guidelines for brain neurotransmission SPECT using (123)I-labelled dopamine transporter ligands, version 2.

P304

e6967

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MD.0000000000006967

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

96

http://www.w3.org/2001/XMLSchema#string

P50

Pier Andrea Serra

P577

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28538394

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

5457874

http://www.w3.org/2001/XMLSchema#string